Fig. 3From: Flavonoids on diabetic nephropathy: advances and therapeutic opportunitiesAntioxidant capacities of flavonoids in diabetic nephropathy. The potential mechanisms involved are primarily the downregulation of Nrf2 signalling, MAPK signalling, TGF-β1/Smad signalling and AGES/RAGE signalling. The red circles represent different bioflavonoids in the relevant regulatory pathways (1) quercetin, (2) baicalin, (3) kaempferol, (4) myricetin, (5) rutin, (6) apigenin, (7) luteolin, (8) naringenin, (9) naringin, (10) hesperetin, (11) genistein, (12) proanthocyanidin, (13) eriodictyol, (14) morin, (15) tangeretinBack to article page